Non-invasive diagnosis of endometriosis: Immunologic and genetic markers

Clin Chim Acta. 2023 Jan 1:538:70-86. doi: 10.1016/j.cca.2022.11.013. Epub 2022 Nov 12.

Abstract

Endometriosis, a benign gynecologic and chronic inflammatory disease, is defined by the presence of endometrial tissue outside the uterus characterized mainly by pelvic pain and infertility. Because endometriosis affects approximately 10% of females, it represents a significant socioeconomic burden worldwide having tremendous impact on daily quality of life. Accurate and prompt diagnosis is crucial for the management of this debilitating disorder. Unfortunately, diagnosis is typically delayed to lack of specific symptoms and readily accessible biomarkers. Although histopathologic examination remains the current gold standard, this approach is highly invasive and not applicable for early screening. Recent work has focused on the identification of reliable biomarkers including immunologic, ie, immune cells, antibodies and cytokines, as well as genetic and biochemical markers, ie, microRNAs, lncRNAs, circulating and mitochondrial nucleic acids, along with some hormones, glycoproteins and signaling molecules. Confirmatory research studies are, however, needed to more fully establish these markers in the diagnosis, progression and staging of these endometrial lesions.

Keywords: Biomarker; Diagnosis; Endometriosis; Peripheral blood; Serum; Urine.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Cytokines / genetics
  • Endometriosis* / diagnosis
  • Endometriosis* / genetics
  • Endometriosis* / pathology
  • Female
  • Genetic Markers
  • Humans
  • MicroRNAs* / genetics
  • Quality of Life

Substances

  • Genetic Markers
  • MicroRNAs
  • Biomarkers
  • Cytokines